Home

EKLOOC Respiratory Trainer – For the healthy as well as pulmonary disease patients.

The EKLOOC Respiratory Trainer method involves resistance breathing using an exercise device. Resistance breathing is beneficial in the presence of Chronic Obstructive Pulmonary Disease (COPD), asthma, exacerbation, neuromuscular disease, pneumonia, and airway infection. It is also useful before and after surgery. Other groups that can benefit from respiratory training are, for example, the elderly, smokers, athletes, and the bedridden. Avoiding hospitalization and prolonging life are some of the benefits to be enjoyed.

The respiratory trainer can be used even while resting and its effects have been well documented, e.g. via CT-scans. Using the trainer generates the same results as regular exercise, increasing lung inflation and bronchial pressure (cm H₂O). This is favorable as low lung inflation, obstructed airways and mucus increase the risk of viral and bacterial pulmonary infections.

Bronchial pressure (cm H₂O) varies greatly during respiratory training. The EKLOOC allows you to increase or decrease the resistance at will, with a simple touch.

The EKLOOC fits in your pocket and is easy to carry with you. Smart disassembly makes for effortless cleaning and disinfection, a feature of particular importance to those susceptible to infection.

Both personnel and patients benefit from the straightforward operation that the EKLOOC affords. When training, the user actively controls the amount of breathing resistance, applying load on exhalation. Breathing against a resistance load causes the lungs to expand and raises bronchial pressure. As measuring bronchial pressure (cm H₂O) is a complicated procedure involving body plethysmography, it is rarely performed. Instead, with the EKLOOC users are able to determine a suitable load for themselves. The simple construction of the device also motivates its usage for working environment and environmental reasons.

The National Board of Health and Welfare’s 2015 national guidelines on asthma and COPD caregiving acknowledges Positive Expiratory Pressure (PEP) as having a positive effect on conditions such as COPD, exacerbation and dyspnea, with or without associated accumulation of mucus, and is a recommended treatment method for these conditions (Line K03.14, recommendation level 2). Note that, in the draft version of the guidelines, measuring bronchial pressure (cm H₂O) was recommended when using PEP. The final guidelines make no such mention.

Kenneth Eliasson, VD
Master of Medical Science in Physiotherapy awarded at Karolinska Institutet